In cells, most of the genome is transcribed into RNA, but only a small proportion of RNAs are actually from the protein-coding regions of the genome.
Why are the non-coding regions transcribed at all? Their function has been mysterious.In cells, DNA is transcribed into RNAs that provide the molecular recipe for cells to make proteins. Most of the genome is transcribed into RNA, but only a small proportion of RNAs are actually from the protein-coding regions of the genome.
‘The regulation of gene expression from enhancers, non-coding regions of the genome more distant from protein-coding regions has been studied by researchers.’
Shelley Berger, a professor of Cell and
Developmental Biology and director of the Penn Epigenetics Institute in
the Perelman School of Medicine at the University of Pennsylvania and Daniel Bose, a postdoctoral fellow in her lab, study
the regulation of gene expression from enhancers, non-coding regions of
the genome more distant from protein-coding regions. Enhancers boost the rate of gene expression from nearby protein-coding genes so a cell can pump out more of a needed protein molecule. A mysterious subset of non-coding RNAs called enhancer RNAs (eRNAs) are transcribed from enhancer sequences. While these are important for boosting gene expression, how they achieve this has been completely unknown.
Shedding new light on these elusive eRNAs, they showed that CBP, an enzyme that activates transcription from enhancers, binds directly to eRNAs. This simple act controls patterns of gene expression in organisms by regulating acetylation, a chemical mark that directs DNA tightly packed in the nucleus of cells to loosen to promote transcription. Their findings are published this week in Cell.
"The cells in our bodies share the same genes and DNA sequences, and differ only in how these genes are expressed," Bose said. "Enhancers and eRNAs are critical for this process. Our work shows an exciting new way that eRNAs produce these different patterns of gene expression. We asked if eRNAs work directly with CBP, and found that they do."
Using biochemical assays, they showed that the region of CBP that binds to RNA also can regulate the ability of CBP to work with chemical mark. By binding to this region, eRNAs can directly stimulate CBPs' acetylation activity.
Advertisement
Knowing more about how enhancers and eRNAs function will help oncologists, since recent DNA sequencing of tumors from humans show that numerous mutations associated with cancers and other diseases occur in enhancer regions of the genome - not in protein-coding regions.
Advertisement
Source-Eurekalert